Bristol Myers Gets Speedy FDA Review of Opdivo/Yervoy Combo in Certain Colorectal Cancer Patients
Bristol Myers said about 5% to 7% of people with metastatic colorectal cancer have microsatellite instability-high or mismatch-repair-deficient tumors, adding that these patients are less likely to ...
pharmaphorum48m
FDA looks at Opdivo/Yervoy in first-line colorectal cancer
The FDA has started a priority review of Bristol Myers Squibb's Opdivo and Yervoy as a first-line therapy for patients with a ...
New PIP payment update for people making a new claim or due award review
Minister for Social Security and Disabilities, Sir Stephen Timms also reassured existing PIP claimants with an outstanding ...
capitalbrief14h
Neuren shares climb on fresh FDA designation
Neuren Pharmaceuticals was among the best-performing ASX 200 stocks in morning trade after securing a rare pediatric disease ...
Premium economy versus budget business class: What you get for the money
Premium economy on full-service airlines can be expensive, but is travelling in a budget airline’s “business” class a worthy ...
er.educause.edu53m
EDUCAUSE QuickPoll Results: Sustainability in Higher Education
Higher education institutions are investing in sustainability initiatives, but their specific goals and challenges remain ...